This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical manufacturer. The $17,447 contract is for the delivery of molecular imaging products for nuclear medicine, specifically Pharmalucence's SC05 Sulfur Colloid radiopharmaceutical kits. The contract has no set-aside designation, indicating open competition. Pharmalucence, Inc. is a for-profit, Subchapter S Corporation...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. The contract is for the provision of radiopharmaceuticals, including specialized nuclear medicine products such as Ga-68 Dotatate, iodine I-123, and technetium-99m, which are used in diagnostic imaging and cancer treatment procedures for veterans and military personnel. The...
This federal contract award, valued at $250,000.00, was issued by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The contract covers the provision of various radiopharmaceuticals, with a period of performance through September 30, 2024. This award is part of a larger Blanket Purchase Agreement (BPA) that Lantheus Medical Imaging holds with the DHA, valued at $6.5 million and...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit company specializing in the supply of radiopharmaceuticals for the VA healthcare system. The $111,392.95 delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $4,038,178.15 with the VA's Veterans Integrated Service Network (VISN) 2 for general radiopharmaceuticals, with a performance period through February 2026. The contract does not...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Medi-Physics, Inc., doing business as GE Healthcare, for the supply of radiopharmaceuticals. The contract has a ceiling value of $100,000.00 and a period of performance ending on September 30, 2019. The contract was awarded on October 1, 2018 and was not set aside for small businesses. The original solicitation was for the procurement of various...
This contract award to Lantheus Medical Imaging, Inc. is a Blanket Purchase Agreement (BPA) call from the Defense Health Agency (DHA) for the delivery of radiopharmaceuticals. The contract has a ceiling value of $15,000.00 and a completion date of September 30, 2024. It is a firm fixed-price contract for the provision of critical nuclear medicine supplies and diagnostic imaging agents, primarily used in medical imaging procedures at military treatment facilities, VA medical centers, and other...
This federal contract award, valued at $115,558.72, was issued by the Defense Health Agency (DHA) to Medi-Physics, Inc., a subsidiary of General Electric Company (GE) that operates as GE Healthcare. The contract is for the delivery of specialized radiopharmaceuticals and molecular imaging agents used in nuclear medicine diagnostic procedures, such as DATSCAN (ioflupane I-123) for diagnosing neurological conditions like Parkinson's disease. The contract is a Blanket Purchase Agreement (BPA)...
This federal contract award is for radiopharmaceuticals and supplies, with a ceiling value of $100,000.00. The contract was awarded to Medi-Physics, Inc., a subsidiary of General Electric Company, and does not have a small business set-aside designation. Medi-Physics, Inc. is a manufacturer of specialized pharmaceutical products used in nuclear medicine procedures, with a focus on radiopharmaceuticals like DATSCAN (ioflupane I-123) for diagnostic imaging. The contract is a Blanket Purchase...
This federal contract award, valued at $103,865.20, was issued by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc. for the provision of general radiopharmaceuticals to support the Veterans Integrated Service Network (VISN) 2 healthcare system. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the company, which provides specialized radiopharmaceutical products to VA medical centers in the northeastern United States....
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED) of the U.S. Navy for the provision of radiopharmaceuticals used in positron emission tomography (PET) and computed tomography (CT) medical imaging procedures. The products to be delivered include fluorodeoxyglucose (FDG), sodium fluoride F-18 (NaF), Axumin (fluciclovine F-18), and Amyvid (florbetapir F-18). The contract has a ceiling value of $249,000.00 and a period of performance through January...